GB983132A - Improvements in or relating to chewable hematinic tablets - Google Patents
Improvements in or relating to chewable hematinic tabletsInfo
- Publication number
- GB983132A GB983132A GB9911/63A GB991163A GB983132A GB 983132 A GB983132 A GB 983132A GB 9911/63 A GB9911/63 A GB 9911/63A GB 991163 A GB991163 A GB 991163A GB 983132 A GB983132 A GB 983132A
- Authority
- GB
- United Kingdom
- Prior art keywords
- sugar
- chewable
- vitamin
- tablets
- hematinic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 10
- 239000003826 tablet Substances 0.000 abstract 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 3
- 229930003268 Vitamin C Natural products 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- 235000019154 vitamin C Nutrition 0.000 abstract 3
- 239000011718 vitamin C Substances 0.000 abstract 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 2
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 abstract 2
- 229930195725 Mannitol Natural products 0.000 abstract 2
- 235000010323 ascorbic acid Nutrition 0.000 abstract 2
- 239000011668 ascorbic acid Substances 0.000 abstract 2
- 229960005070 ascorbic acid Drugs 0.000 abstract 2
- 238000005469 granulation Methods 0.000 abstract 2
- 230000003179 granulation Effects 0.000 abstract 2
- 235000010355 mannitol Nutrition 0.000 abstract 2
- 239000000594 mannitol Substances 0.000 abstract 2
- DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 abstract 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 abstract 1
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 abstract 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 abstract 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 abstract 1
- 238000007906 compression Methods 0.000 abstract 1
- 230000006835 compression Effects 0.000 abstract 1
- 239000000975 dye Substances 0.000 abstract 1
- 239000011773 ferrous fumarate Substances 0.000 abstract 1
- 235000002332 ferrous fumarate Nutrition 0.000 abstract 1
- 229960000225 ferrous fumarate Drugs 0.000 abstract 1
- 239000011790 ferrous sulphate Substances 0.000 abstract 1
- 235000003891 ferrous sulphate Nutrition 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000019634 flavors Nutrition 0.000 abstract 1
- 229940050410 gluconate Drugs 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000007942 layered tablet Substances 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 235000010755 mineral Nutrition 0.000 abstract 1
- 159000000000 sodium salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000009495 sugar coating Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 235000019156 vitamin B Nutrition 0.000 abstract 1
- 239000011720 vitamin B Substances 0.000 abstract 1
- 229940046001 vitamin b complex Drugs 0.000 abstract 1
- 239000000080 wetting agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18566462A | 1962-04-06 | 1962-04-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB983132A true GB983132A (en) | 1965-02-10 |
Family
ID=22681943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9911/63A Expired GB983132A (en) | 1962-04-06 | 1963-03-13 | Improvements in or relating to chewable hematinic tablets |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US3125491A (en:Method) |
| BE (1) | BE629982A (en:Method) |
| FR (1) | FR3472M (en:Method) |
| GB (1) | GB983132A (en:Method) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2081436A1 (en:Method) * | 1970-01-15 | 1971-12-03 | Scherer Corp R P | |
| GB2157167A (en) * | 1981-04-13 | 1985-10-23 | Orthomolecular Inc | Sublingual vitamin b12 lozenges |
| CN110327303A (zh) * | 2019-08-15 | 2019-10-15 | 威海百合生物技术股份有限公司 | 一种铁维生素c片剂及其制备方法 |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3476571A (en) * | 1966-05-19 | 1969-11-04 | Gen Foods Corp | Artificially sweetened fruit-flavored product |
| US4260596A (en) * | 1979-08-13 | 1981-04-07 | Bristol-Myers Company | Edible unit dosage form consisting of outer mannitol shell and inner liquid or gel center and method for manufacturing the same |
| JPH01500113A (ja) * | 1986-04-07 | 1989-01-19 | クレメトソン，チヤールズ，エー．，ビー． | カテキンで被覆されたアスコルビン酸及び方法 |
| US4752479A (en) * | 1986-05-27 | 1988-06-21 | Ciba-Geigy Corporaton | Multi vitamin and mineral dietary supplement with controlled release bioavailable iron |
| US6488956B1 (en) * | 1994-06-20 | 2002-12-03 | Drugtech Corporation | Multi-vitamin and mineral supplements for women |
| US6352713B1 (en) | 1999-12-01 | 2002-03-05 | Drugtech Corporation | Nutritional composition |
| KR100267576B1 (ko) | 1998-07-25 | 2000-11-01 | 허계성 | 활성성분을 분리함유한 츄잉 연질정제 및 그의 제조방법 |
| US6663892B1 (en) | 2002-08-19 | 2003-12-16 | L. Perrigo Company | Multiple portion tablet |
| EP1615626B1 (en) * | 2003-04-24 | 2009-10-14 | Jagotec Ag | Tablet with coloured core |
| HRP20130148T4 (hr) | 2006-08-03 | 2016-10-07 | Horizon Pharma Ag | Liječenje reumatske bolesti glukokortikoidima s odgođenim otpuštanjem |
| WO2010084188A1 (en) * | 2009-01-26 | 2010-07-29 | Nitec Pharma Ag | Delayed-release glucocorticoid treatment of asthma |
| NZ582836A (en) * | 2009-01-30 | 2011-06-30 | Nitec Pharma Ag | Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage |
| DE102011122250A1 (de) * | 2011-10-24 | 2013-04-25 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Eisenhaltige Vitaminzusammensetzung |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2410110A (en) * | 1943-01-14 | 1946-10-29 | Brewer & Company Inc | Method of making tablets |
| US2996431A (en) * | 1953-12-16 | 1961-08-15 | Barry Richard Henry | Friable tablet and process for manufacturing same |
| US2811483A (en) * | 1954-12-09 | 1957-10-29 | Pfizer & Co C | Pharmaceutical composition and process for preparing the same |
| US2822317A (en) * | 1955-12-12 | 1958-02-04 | Smith Kline French Lab | Aqueous iron-ascorbic acid preparation |
| CA572556A (en) * | 1956-05-18 | 1959-03-17 | Mallinckrodt Chemical Works | Iron compound and methods of preparation |
| US2887436A (en) * | 1956-05-28 | 1959-05-19 | Pfizer & Co C | Pharmaceutical compositions |
| US2939820A (en) * | 1956-06-11 | 1960-06-07 | Pfizer & Co C | Aqueous vitamin and mineral compositions |
| US2985559A (en) * | 1958-01-27 | 1961-05-23 | Glaxo Lab Ltd | Stabilized therapeutic ferrous fumarate aqueous suspensions |
| GB851761A (en) * | 1958-01-27 | 1960-10-19 | Glaxo Lab Ltd | Therapeutic compositions containing ferrous fumarate |
| US3019169A (en) * | 1958-06-23 | 1962-01-30 | Sterling Drug Inc | Salicylate dry shell coating of dry 4-aminoquinoline core, and dry-compressing tablet-making process |
| US3048526A (en) * | 1958-08-04 | 1962-08-07 | Wander Company | Medicinal tablet |
-
0
- BE BE629982D patent/BE629982A/xx unknown
- US US3125491D patent/US3125491A/en not_active Expired - Lifetime
-
1963
- 1963-03-13 GB GB9911/63A patent/GB983132A/en not_active Expired
- 1963-03-26 FR FR929182A patent/FR3472M/fr not_active Expired
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2081436A1 (en:Method) * | 1970-01-15 | 1971-12-03 | Scherer Corp R P | |
| GB2157167A (en) * | 1981-04-13 | 1985-10-23 | Orthomolecular Inc | Sublingual vitamin b12 lozenges |
| CN110327303A (zh) * | 2019-08-15 | 2019-10-15 | 威海百合生物技术股份有限公司 | 一种铁维生素c片剂及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| BE629982A (en:Method) | |
| FR3472M (fr) | 1965-08-09 |
| US3125491A (en) | 1964-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB983132A (en) | Improvements in or relating to chewable hematinic tablets | |
| ES487151A1 (es) | Procedimiento de preparacion de nuevas formas galenicas de administracion de medicamentos por via oral, con liberacion programada | |
| ATE189771T1 (de) | Zubereitung mit kontrollierter freisetzung, die ein morphinsalz enthält | |
| CA2136411A1 (en) | Immediate Release Tablet Cores of Insoluble Drugs Having Sustained Release Coating | |
| EP0195643A3 (en) | Compositions and method of controlling transdermal penetration of topical and systemic agents | |
| ATE19589T1 (de) | Pharmazeutische dreilagen-filmpraeparate mit lang anhaltender wirkung. | |
| AU2506388A (en) | Azelastine-containing medicaments for application in the nose and/or at the eye | |
| JPS57212114A (en) | Capsule containing allergen activator and preparation therefor | |
| EP0096286A3 (de) | Hydrolyseempfindlichen Wirkstoff enthaltende, lagerstabile Tablette | |
| Walker et al. | Dermal copper drugs: the copper bracelet and Cu (II) salicylate complexes | |
| EP0302714A3 (en) | Pharmaceutical composition for treatment of bone-wasting diseases | |
| RU2110254C1 (ru) | Композиция для профилактики и лечения гриппа и орви | |
| ATE102480T1 (de) | Multigranulaere tablette mit verzoegerter freisetzung. | |
| GB1422193A (en) | Pharmaceutical compositions | |
| Zsotér et al. | Effect of thyroid hormones on vascular response | |
| US3039922A (en) | Method of administering tablets having decongestant and anti-histaminic activity | |
| Samniah et al. | Cerebral infarction associated with oral verapamil overdose | |
| GB1352257A (en) | Pyridyltriazoles their preparation and compositions containing them | |
| GB1210968A (en) | Improvements in or relating to the treatment of gastric ailments | |
| ES264510A1 (es) | Metodo para la preparaciën de preparados de hierro de elevado poder de absorciën | |
| GR3004113T3 (en:Method) | ||
| JPS56138110A (en) | Suppository containing citric acid or salt thereof | |
| GB1153324A (en) | Sustained Release Tablets | |
| DE2743702A1 (de) | Abmagerungs- oder schlankmacher- zubereitung und verfahren zu ihrer herstellung | |
| GB1375806A (en:Method) |